Muscle growth in the human body is tightly controlled by biological signals that prevent excessive tissue development. One of the most important regulators of this process is myostatin, a protein that acts as a natural limit on muscle size. Because of its role in restricting muscle growth, researchers have long investigated ways to temporarily block or modulate myostatin activity as a potential strategy for treating muscle-wasting conditions.
This research led to the development of compounds designed to interfere with the signaling pathways that regulate muscle mass. Among them is ACE-031, also known as Ramatercept, an investigational fusion protein created to bind proteins involved in the myostatin signaling pathway and alter how the body regulates muscle development.
Key Takeaways
ACE-031 (Ramatercept) is an investigational fusion protein designed to inhibit myostatin, a protein that normally limits muscle growth.
It works by mimicking the activin type IIB receptor (ActRIIB), binding to myostatin and related proteins so they cannot signal muscle cells to restrict growth.
Blocking myostatin may increase muscle mass, strength, and muscle fiber size, which is why ACE-031 has been studied for conditions like Duchenne muscular dystrophy.
Early clinical studies showed increases in lean body mass and muscle volume, though some trials were stopped due to side effects such as nosebleeds and vascular changes.
What is ACE-031 or Ramatercept
Mechanism of Action
ACE-031 and Muscle Growth
Myostatin and Its Impact on Muscle Health
In these conditions, muscles struggle to repair and regenerate, leading to progressive weakness. Myostatin inhibitory peptides, could counteract this effect, offering a way to restore muscle function.
The Science Behind Myostatin Inhibitory Peptides
Research and Clinical Studies on ACE-031
Determined Safety Profile and Potential Side Effects
Potential Benefits of Ace-031
ACE-031 offers a range of promising benefits for muscle development and overall health, particularly for those facing muscle-wasting conditions. This compound blocks myostatin, a protein that naturally limits muscle growth, allowing muscle tissue to develop more than usual. Muscle strength can improve as a result, helping patients with neuromuscular diseases regain and maintain their ability to perform everyday tasks.
Stronger muscles can improve respiratory function in muscular dystrophies that affect breathing muscles, bringing relief and better overall health. Increased muscle strength also helps reduce the risk of osteoporosis by maintaining bone density, which is especially important for those who are less active. Muscles play an important role in how the body uses energy, so keeping them strong can support a healthier metabolism.
Final Word
ACE-031 stands out as a unique approach to addressing muscle weakness and degeneration. Designed to inhibit myostatin, this peptide shows potential in treating conditions like Duchenne muscular dystrophy and age-related muscle loss. Research also points to its promise in supporting recovery from injury and enhancing physical performance in sports.
While studies so far reveal encouraging data, ACE-031 remains in the early stages of exploration. As new trials and data emerge, this peptide continues to hold promise as a breakthrough treatment for improving muscle strength, restoring function, and elevating quality of life for those facing muscle-related challenges.
Sourcing
USA
LIMITLESS LIFE NOOTROPICS aka Biotech
Use Discount Code: EP20
SCANTIFIX
Use Discount Code: Exploringpeptides
Canada
BIOSLAB
Use Discount Code: EP10
Europe
DNLABResearch
Use Discount Code: EP15
Australia
LVLUPHEALTH
References
[1] Attie KM, Borgstein NG, Yang Y, Condon CH, Wilson DM, Pearsall AE, Kumar R, Willins DA, Seehra JS, Sherman ML. A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle Nerve. 2013 Mar;47(3):416-23. doi: 10.1002/mus.23539. Epub 2012 Nov 21. PMID: 23169607.
[2] Campbell C, McMillan HJ, Mah JK, Tarnopolsky M, Selby K, McClure T, Wilson DM, Sherman ML, Escolar D, Attie KM. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial. Muscle Nerve. 2017 Apr;55(4):458-464. doi: 10.1002/mus.25268. Epub 2016 Dec 23. PMID: 27462804.
[3] Jang J, Park S, Kim Y, Jung J, Lee J, Chang Y, Lee SP, Park BC, Wolfe RR, Choi CS, Kim IY. Myostatin Inhibition-Induced Increase in Muscle Mass and Strength Was Amplified by Resistance Exercise Training, and Dietary Essential Amino Acids Improved Muscle Quality in Mice. Nutrients. 2021 Apr 29;13(5):1508. doi: 10.3390/nu13051508. PMID: 33947024; PMCID: PMC8146053.
[4] Buehring B, Binkley N. Myostatin--the holy grail for muscle, bone, and fat? Curr Osteoporos Rep. 2013 Dec;11(4):407-14. doi: 10.1007/s11914-013-0160-5. PMID: 24072591.
Table of content
Related articles
SLU-PP-915: Benefits, Research & Comparison with SLU-PP-332
Adalank vs Selank: Differences, Benefits and Effects
Adamax vs Semax: Comparison, Benefits, and Effects
Common Mistakes When Reconstituting Peptides
Peptides Vs Proteins: What’s The Difference?
What Are Peptides and How Do They Work?